Login to Your Account



£12M For Intercytex Will Fund Wound Product Phase III Trial

By Nuala Moran


Wednesday, August 10, 2005
No Abstract

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription